PneumoWave
PneumoWave is revolutionizing respiratory care through its integrated platform for patient data capture and analysis, utilizing a custom-designed, small, chest-worn biosensor. Their product pipeline includes DCM, an activity monitor for documenting physical movement, and ALERT, a solution for real-time monitoring of opioid-induced respiratory depression and other life-threatening conditions. By harnessing advanced data analytics, PneumoWave empowers timely interventions that can save lives, aiming for a paradigm shift in patient care by focusing on intervention before disease or injury advances. The company has secured significant funding, including a £7.5 million Series A round, and has achieved ISO 13485:2016 certification and UKCA Class 1 registration. PneumoWave is actively involved in clinical trials and collaborations with institutions like King's College London and NHS Greater Glasgow & Clyde.
PneumoWave
PneumoWave is revolutionizing respiratory care through its integrated platform for patient data capture and analysis, utilizing a custom-designed, small, chest-worn biosensor. Their product pipeline includes DCM, an activity monitor for documenting physical movement, and ALERT, a solution for real-time monitoring of opioid-induced respiratory depression and other life-threatening conditions. By harnessing advanced data analytics, PneumoWave empowers timely interventions that can save lives, aiming for a paradigm shift in patient care by focusing on intervention before disease or injury advances. The company has secured significant funding, including a £7.5 million Series A round, and has achieved ISO 13485:2016 certification and UKCA Class 1 registration. PneumoWave is actively involved in clinical trials and collaborations with institutions like King's College London and NHS Greater Glasgow & Clyde.
TL;DR
Sector: Wearable respiratory biosensors and real‑time monitoring platform
Founded: 2018
HQ / Presence: Scotland and United States
Employees: 22
Latest disclosed round: £7.5M Series A (closed 2023-01-12)
Total funding (reported): $12.26M
Company Overview
Problem Domain
Remote patient monitoring and respiratory event detection in clinical and at‑risk settings.
Founded
2018
Industry
Digital health / Medtech
Funding Track Record
£7,500,000
Round comprised £5.2M from Scottish National Investment Bank and ~£2.3M from existing investors
Investor Signal
“Backed by public and regional investors including Scottish National Investment Bank and Scottish Enterprise”